s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
DEF 14C
Definitive information statements
Filed
Monday, April 13, 2026
Period
Apr 13, 2026
Accession number
0001493152-26-016310
Documents
DEF 14C
DEF 14C
On sec.gov
Filing index
All files
Complete submission text
SGML header